🇺🇸 FDA
Patent

US 11208470

DNA antibody constructs and method of using same

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 11208470 (DNA antibody constructs and method of using same) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K31/7088, A61K39/12